Serum potassium levels and its variability in incident peritoneal dialysis patients: Associations with mortality

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Xu, Qingdong ^a   Xu, Fenghua ^a   Fan, Li ^a   Xiong, Liping ^a   Li, Huiyan ^a   Cao, Shirong ^a   Lin, Xiaoyan ^a   Zheng, Zhihua ^a   Yu, Xueqing ^a   Mao, Haiping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; POTASSIUM; POTASSIUM DERIVATIVE;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HYPERKALEMIA; HYPOKALEMIA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PREDICTIVE VALUE; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SHORT TERM SURVIVAL;

ADULT; AGED; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPOKALEMIA; MALE; MIDDLE AGED; MORTALITY; PERITONEAL DIALYSIS; POTASSIUM; PROPORTIONAL HAZARDS MODELS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 84900322980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086750     Document Type: Article

References (34)

1. Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, et al. (2010) Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol 5: 762-769.
2. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, et al. (2007) Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999-1007.
3. Oreopoulos DG, Khanna R, Williams P, Vas SI (1982) Continuous ambulatory peritoneal dialysis - 1981. Nephron 30: 293-303. (Pubitemid 12089178)
4. Rostand SG (1983) Profound hypokalemia in continuous ambulatory peritoneal dialysis. Arch Intern Med 143: 377-378.
5. Khan AN, Bernardini J, Johnston JR, Piraino B (1996) Hypokalemia in peritoneal dialysis patients. Perit Dial Int 16: 652.
6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305.
7. Harrison TR, Pilcher C, Ewing G (1930) STUDIES IN CONGESTIVE HEART FAILURE: IV. The Potassium Content of Skeletal and Cardiac Muscle. J Clin Invest 8: 325-335.
8. Szeto CC, Chow KM, Kwan BC, Leung CB, Chung KY, et al. (2005) Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. Am J Kidney Dis 46: 128-135. (Pubitemid 40848441)
9. Torlen K, Kalantar-Zadeh K, Molnar MZ, Vashistha T, Mehrotra R (2012) Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol 7: 1272-1284.
10. Kwan BC, Szeto CC (2012) Dialysis: Hypokalaemia and cardiac risk in peritoneal dialysis patients. Nat Rev Nephrol 8: 501-503.
11. Beddhu S, Zeidel ML, Saul M, Seddon P, Samore MH, et al. (2002) The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 112: 696-701. (Pubitemid 34655657)
12. Rocco MV, Jordan JR, Burkart JM (1994) Determination of peritoneal transport characteristics with 24-hour dialysate collections: dialysis adequacy and transport test. J Am Soc Nephrol 5: 1333-1338. (Pubitemid 24977117)
13. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, et al. (2003) Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 18: 797-803. (Pubitemid 36432264)
14. van Olden RW, Krediet RT, Struijk DG, Arisz L (1996) Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 7: 745-750. (Pubitemid 27466008)
15. Davies SJ, Phillips L, Naish PF, Russell GI (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12: 1046-1051. (Pubitemid 32378346)
16. Wang AY, Wang M, Woo J, Lam CW, Li PK, et al. (2003) Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 14: 159-168. (Pubitemid 36032720)
17. Chertow GM, Block GA, Correa-Rotter R, Drueke TB, Floege J, et al. (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367: 2482-2494.
18. Dekker FW, de Mutsert R, van Dijk PC, Zoccali C, Jager KJ (2008) Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int 74: 994-997.
19. McDonald SP, Collins JF, Johnson DW (2003) Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 14: 2894-2901. (Pubitemid 37305652)
20. Royston P (2000) A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Statistics in medicine 19: 1831-1847.
21. Chuang YW, Shu KH, Yu TM, Cheng CH, Chen CH (2009) Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant 24: 1603-1608.
22. Jung JY, Chang JH, Lee HH, Chung W, Kim S (2009) De novo hypokalemia in incident peritoneal dialysis patients: a 1-year observational study. Electrolyte Blood Press 7: 73-78.
23. Tziviskou E, Musso C, Bellizzi V, Khandelwal M, Wang T, et al. (2003) Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: one center's experience and review of the literature. Int Urol Nephrol 35: 429-434. (Pubitemid 39127563)
24. Gao H, Lew SQ, Bosch JP (1999) Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients. Am J Nephrol 19: 7-12. (Pubitemid 29139864)
25. Newman LN, Weiss MF, Berger J, Priester A, Negrea LA, et al. (2000) The law of unintended consequences in action: increase in incidence of hypokalemia with improved adequacy of dialysis. Adv Perit Dial 16: 134-137.
26. Li PK, Chow KM, Wong TY, Leung CB, Szeto CC (2003) Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 139: 105-112.
27. Sica DA, Struthers AD, Cushman WC, Wood M, Banas JS Jr, et al. (2002) Importance of potassium in cardiovascular disease. J Clin Hypertens (Greenwich) 4: 198-206. (Pubitemid 34678928)
28. Fleischmann EH, Bower JD, Salahudeen AK (2001) Risk factor paradox in hemodialysis: better nutrition as a partial explanation. ASAIO J 47: 74-81. (Pubitemid 32057962)
29. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD (2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63: 793-808. (Pubitemid 36315558)
30. Chan CT (2008) Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol Dial Transplant 23: 3061-3062.
31. Di Iorio B, Pota A, Sirico ML, Torraca S, Di Micco L, et al. (2012) Blood pressure variability and outcomes in chronic kidney disease. Nephrol Dial Transplant 27: 4404-4410.
32. Kainz A, Mayer B, Kramar R, Oberbauer R (2010) Association of ESA hyporesponsiveness and haemoglobin variability with mortality in haemodialysis patients. Nephrol Dial Transplant 25: 3701-3706.
33. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, et al. (2006) Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780. (Pubitemid 44215354)
34. Bleyer AJ, Russell GB, Satko SG (1999) Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55: 1553-1559. (Pubitemid 29157156)